Check the

ARC TRINOVA LIMITED

Company
ARC TRINOVA LIMITED (09767194)

ARC TRINOVA

Phone: 01665 608 300
A rating

ABOUT ARC TRINOVA LIMITED

A multi-service Contract Research and Development Organisation (CRDO), Arcinova serves the global pharmaceutical and biotechnology communities and offers a wide range of integrated specialist services, including drug substance synthesis, drug product manufacture, the development, validation and application of analytical and microbiological methodology, bioanalytical and metabolism services, radiolabelling synthesis and drug product manufacture, and synthesis and testing of toxic/highly potent APIs.

Businesses can harness the world-class, specialist research and development knowledge of our scientists to support them in developing and delivering new products, and our 15,000m2  site provides extensive specialist facilities. 

European Biotech Company

A client has developed new product to fulfil an unmet patient need. Pivotal clinical studies require highly sensitive, precise measurement of multiple insulin analogues from a small volume of plasma.

US Biotech company, commenting on CMC and API Development.

"We are very impressed with the high quality work Arcinova provided in all aspects. We strongly recommend Arcinova. It has been a great pleasure to work with the Arcinova team",

"We are very impressed with Arcinova's high quality work. Thank you very much for the excellent results and report!

US Biotech company, commenting on CMC.

Top 10 Global Pharma company, commenting on CMC

US Biotech company, commenting on CMC Dossiers

US Biotech company, commenting on CMC [formulation development]

“…worked effectively and hard to deal with issues as they arose… to keep the project on schedule… to meet timelines for production of a high quality report….and gave high quality support to the sponsor”, 

UK Biotech company, commenting on a cross-functional project [CMC and DMPK]

UK multinational company, commenting on CMC

“The Alnwick team could always give us quick, kindly and professional responses during the study and it was very helpful for us”, 

Asia-Pac Large Pharma company, commenting on API [GMP radiosynthesis]

Top 10 Global Pharma company, commenting on DMPK

Top 10 Pharma company, commenting on DMPK

US Biotech company commenting on CMC

We work to enhance the health and wellbeing of society by helping companies to develop life changing medicines and take them to market quickly, effectively and efficiently. 

Our focus is on API process research, the development, validation and application of analytical, microbiological and materials science spectroscopic methodologies, scale-up and early phase clinical product manufacturing. We also provide non-clinical and clinical carbon-14 API, drug product bioanalysis, DMPK, regulatory and consulting services.

Operating from a 15,000m2 site and offering world class facilities, Arcinova provides both end to end solutions and standalone services to pharmaceutical and biotechnology companies across the world.

Google Maps/Satellite Navigation Systems do not give the correct location when entering the Arcinova postcode (NE66 2DH). Please search ‘Arcinova’ or ‘Taylor Drive, Alnwick’ instead of the postcode. We are located off Willowburn Avenue (NE66 2JH).

An opportunity has arisen for someone to join Arcinova's Business Development team. This is a remote position on a full-time basis, reporting to the Head of Business Development. 

KEY FINANCES

Year
2016
Assets
£3361.02k
Cash
£1301.62k
Liabilities
£651.71k
Net Worth
£2709.31k

REGISTRATION INFO

Company name
ARC TRINOVA LIMITED
Company number
09767194
Status
Active
Categroy
Private Limited Company
Date of Incorporation
08 Sep 2015
Age - 6 years
Home Country
United Kingdom

CONTACTS

Website
arcinova.uk
Phones
01665 608 300
Registered Address
TAYLOR DRIVE,
ALNWICK,
NORTHUMBERLAND,
NE66 2DH

ECONOMIC ACTIVITIES

72110
Research and experimental development on biotechnology

LAST EVENTS

22 Dec 2016
Registration of charge 097671940001, created on 21 December 2016
21 Sep 2016
Confirmation statement made on 7 September 2016 with updates
23 Jun 2016
Current accounting period extended from 30 September 2016 to 31 December 2016

CHARGES

21 December 2016
Status
Outstanding
Delivered
22 December 2016
Persons entitled
The North East Growth 500 Plus LP Acting by Its General Partner Ne Growth 500 LP Limited Acting by Fw Capital Limited
Description
All freehold and leasehold property now or in the future…

See Also

ARC TRINOVA LIMITED DIRECTORS

Paul Christopher Ryan

  Acting PSC
Appointed
11 December 2015
Occupation
Company Director
Role
Director
Age
57
Nationality
British
Address
Taylor Drive, Alnwick, Northumberland, NE66 2DH
Country Of Residence
England
Name
RYAN, Paul Christopher
Notified On
6 September 2016
Nature Of Control
Ownership of shares – More than 25% but not more than 50%

Ian Dermot Shott

  Acting PSC
Appointed
11 December 2015
Occupation
Company Director
Role
Director
Age
65
Nationality
British
Address
Taylor Drive, Alnwick, Northumberland, NE66 2DH
Country Of Residence
England
Name
SHOTT, Ian Dermot
Notified On
6 September 2016
Nature Of Control
Ownership of shares – More than 50% but less than 75%

James Henry Pass

  Resigned
Appointed
08 September 2015
Resigned
11 December 2015
Occupation
Solicitor
Role
Director
Age
58
Nationality
British
Address
St Ann's Wharf, 112 Quayside, Newcastle Upon Tyne, United Kingdom, NE1 3DX
Country Of Residence
United Kingdom
Name
PASS, James Henry

REVIEWS


Check The Company
Excellent according to the company’s financial health.